Citigroup’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4
| Closed | -$90 | – | 4855 |
|
|
2022
Q4 | $90 | Hold |
4
| – | – | ﹤0.01% | 4834 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 5248 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5602 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5558 |
|
|
2021
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 5166 |
|
|
2020
Q1 | – | Sell |
-200
| Closed | -$23K | – | 5156 |
|
|
2019
Q4 | $23K | Buy |
+200
| New | +$23K | ﹤0.01% | 4441 |
|
|
2018
Q3 | – | Sell |
-2
| Closed | – | – | 5095 |
|
|
2018
Q2 | $0 | Sell |
2
-280
| -99% | – | ﹤0.01% | 5036 |
|
|
2018
Q1 | $35K | Buy |
282
+149
| +112% | +$18.5K | ﹤0.01% | 3956 |
|
|
2017
Q4 | $8K | Buy |
133
+129
| +3,225% | +$7.76K | ﹤0.01% | 4563 |
|
|
2017
Q3 | $0 | Sell |
4
-7
| -64% | – | ﹤0.01% | 4796 |
|
|
2017
Q2 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 4721 |
|